LEI 969500HU0LDLDZW7HU66
CHU BESANCON
Group parent: REPUBLIQUE FRANCAISE PRESIDENCE
Contract awards & public grants
Soft Active Matter Microrobots for Medicine → CHU DE BESANCON
European Commission · FR · Grant · 2026-06-11
—
Monitoring multidimensional aspects of QUAlity of Life after cancer ImmunoTherapy - an Open smart digital Platform for personalized prevention and pat → CHU DE BESANCON
European Commission · FR · Grant · 2019-10-28
—
Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative → CHU DE BESANCON
European Commission · FR · Grant · 2017-11-21
—
REgenerative Stem cell therapy for STroke in Europe → CHU DE BESANCON
European Commission · FR · Grant · 2015-09-15
€1,700
Secondary prEvention of CardiovascUlaR disease in the Elderly trial → CHU DE BESANCON
European Commission · FR · Grant · 2015-04-08
€232,609
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.